1. Home
  2. MGTX vs BARK Comparison

MGTX vs BARK Comparison

Compare MGTX & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

BUY

Current Price

$10.73

Market Cap

1.0B

Sector

Health Care

ML Signal

BUY

Logo BARK Inc.

BARK

BARK Inc.

N/A

Current Price

$8.17

Market Cap

73.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
MGTX
BARK
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
73.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
MGTX
BARK
Price
$10.73
$8.17
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
★ $27.75
$15.50
AVG Volume (30 Days)
★ 932.8K
46.7K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.02
N/A
EPS
★ 1.30
0.08
Revenue
$81,391,000.00
★ $394,843,000.00
Revenue This Year
$314.19
N/A
Revenue Next Year
N/A
$4.97
P/E Ratio
★ $8.22
$106.50
Revenue Growth
★ 144.57
N/A
52 Week Low
$6.62
$0.50
52 Week High
$15.35
$11.32

Technical Indicators

Market Signals
Indicator
MGTX
BARK
Relative Strength Index (RSI) 28.57 36.78
Support Level $8.84 $0.59
Resistance Level $11.85 $9.86
Average True Range (ATR) 0.57 0.36
MACD -0.19 -0.02
Stochastic Oscillator 8.18 11.90

Price Performance

Historical Comparison
MGTX
BARK

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

About BARK BARK Inc.

BARK Inc believe that dogs and humans are good together and it aspire to be the world's favorite dog brand. It is a team of dog-obsessed people committed to delivering personalization at scale by satisfying each dog's distinct personality, preferences, and needs with the products and services. It is an omnichannel brand that designs and develops proprietary products for dogs across two key brands: BarkBox and Super Chewer. All of its products are designed and developed in-house, and are BARK branded. Its segments are DTC, and Commerce. It generates majority of revenue from DTC. Direct to Consumer generates revenue from subscription products that feature monthly themes of premium quality BarkBox and Super Chewer toys and BARK-branded treats and chews.

Share on Social Networks: